how many americans are taking glp 1 drugs A new study reports a record number of now using GLP-1 weight loss drugs, signaling a sharp shift in the country approaches obesity treatment and demand for these medications How Many People Take GLP-1

Health Sci

The vision loss connection demonstrates an even more troubling pattern

Ognard J, El Hajj G, Ghozy S et al (2025) Quality of life in patients with spontaneous intracranial hypotension: A systematic review and meta-analysis

Tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) activates two receptors GLP-1 and GIP which is why it tends to produce somewhat stronger weight-loss results on average

The immunopathogenesis is driven by a predominance of T helper (Th)1-mediated immune responses, with elevated interferon- (IFN-) production and impaired function of regulatory T cells (Tregs), which normally restrain autoreactive lymphocytes [11,12]